To learn more about these conditions and how hydroxyzine is used for them, see the “What is hydroxyzine used for?” section below. Hydroxyzine is classified as an antihistamine. You’ll take hydroxyzine ...

Hydroxyzine is a commonly prescribed antihistamine used to treat allergies, itching, and anxiety. Hydroxyzine can interact with various medications and substances, including central nervous system ...

Hydroxyzine (whose brand names include Vistaril) and Benadryl (the brand name of diphenhydramine) are both first-generation antihistamines and share many similarities, including sedating side effects.

Discover comprehensive details about Hydroxyzine, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Are you taking Hydroxyzine? Are you aware of the dangers of combining Hydroxyzine with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side ...

Physicians should take certain precautions in prescribing the first-generation antihistamine hydroxyzine to minimize the drug’s risk for potentially fatal heart arrhythmias, the European Medicines ...

The European Medicines Agency's (EMA's) Pharmacovigilance Risk Assessment Committee (PRAC) is reviewing the safety of hydroxyzine-containing medicines because of cardiac concerns.

Patients with cirrhosis and minimal hepatic encephalopathy often experience sleep difficulties, but treatment with benzodiazepines is frequently ineffective and can have serious side effects.

Hydroxyzine is an antihistamine that can help treat anxiety, allergies, itchy skin, and some rashes. No recent research has identified potential interactions between hydroxyzine and cannabis, but this ...

A common medication used by allergy sufferers may offer relief to cirrhosis patients that suffer from insomnia. A new study shows that the antihistamine hydroxyzine is an effective treatment for ...

Hydroxyzine Hydrochloride Tablets had U.S. sales of approximately $55 million for the 12 months ending March 31, 2010, according to IMS Health. Currently, Mylan has 138 ANDAs pending FDA approval ...

Impact of fish-oil supplement on nutritional parameters, inflammation and chemotherapy induced toxicity in colorectal cancer (CRC) patients receiving FOLFIRI- a pilot study No significant financial ...